In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk.
Where this comes from
- Record sourced from PubMed, PMID 34606316.
- Also identified by DOI 10.7326/ACPJ202110190-110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Jankowska EA, Kirwan BA, Kosiborod M, et al. <b>The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.</b> Eur Heart J. 2021;42:3011-20. 34080008.
Medical subject headings
- Anemia, Iron-Deficiency
- Heart Failure